Ravulizumab; Solution concentrate for I.V. infusion 300 mg in 3 mL, Solution concentrate for I.V. infusion 1,100 mg in 11 mL; Ultomiris®
Page last updated: 3 September 2025
Page last updated: 3 September 2025
© Commonwealth of Australia
ABN: 83 605 426 759